AAPL   325.12 (+0.55%)
MSFT   185.36 (+0.24%)
FB   230.16 (-1.10%)
GOOGL   1,439.25 (-0.21%)
AMZN   2,478.40 (+0.24%)
NVDA   350.78 (-0.63%)
CGC   16.57 (+2.66%)
BABA   218.61 (+2.00%)
MU   48.92 (+4.49%)
GE   7.36 (+4.40%)
TSLA   882.96 (+0.16%)
AMD   52.73 (-1.51%)
T   31.51 (+1.68%)
ACB   14.30 (-1.58%)
F   6.19 (+4.92%)
GILD   74.40 (+1.56%)
DIS   122.18 (+2.89%)
NFLX   421.97 (-1.25%)
BAC   25.99 (+4.63%)
BA   173.16 (+12.95%)
AAPL   325.12 (+0.55%)
MSFT   185.36 (+0.24%)
FB   230.16 (-1.10%)
GOOGL   1,439.25 (-0.21%)
AMZN   2,478.40 (+0.24%)
NVDA   350.78 (-0.63%)
CGC   16.57 (+2.66%)
BABA   218.61 (+2.00%)
MU   48.92 (+4.49%)
GE   7.36 (+4.40%)
TSLA   882.96 (+0.16%)
AMD   52.73 (-1.51%)
T   31.51 (+1.68%)
ACB   14.30 (-1.58%)
F   6.19 (+4.92%)
GILD   74.40 (+1.56%)
DIS   122.18 (+2.89%)
NFLX   421.97 (-1.25%)
BAC   25.99 (+4.63%)
BA   173.16 (+12.95%)
AAPL   325.12 (+0.55%)
MSFT   185.36 (+0.24%)
FB   230.16 (-1.10%)
GOOGL   1,439.25 (-0.21%)
AMZN   2,478.40 (+0.24%)
NVDA   350.78 (-0.63%)
CGC   16.57 (+2.66%)
BABA   218.61 (+2.00%)
MU   48.92 (+4.49%)
GE   7.36 (+4.40%)
TSLA   882.96 (+0.16%)
AMD   52.73 (-1.51%)
T   31.51 (+1.68%)
ACB   14.30 (-1.58%)
F   6.19 (+4.92%)
GILD   74.40 (+1.56%)
DIS   122.18 (+2.89%)
NFLX   421.97 (-1.25%)
BAC   25.99 (+4.63%)
BA   173.16 (+12.95%)
AAPL   325.12 (+0.55%)
MSFT   185.36 (+0.24%)
FB   230.16 (-1.10%)
GOOGL   1,439.25 (-0.21%)
AMZN   2,478.40 (+0.24%)
NVDA   350.78 (-0.63%)
CGC   16.57 (+2.66%)
BABA   218.61 (+2.00%)
MU   48.92 (+4.49%)
GE   7.36 (+4.40%)
TSLA   882.96 (+0.16%)
AMD   52.73 (-1.51%)
T   31.51 (+1.68%)
ACB   14.30 (-1.58%)
F   6.19 (+4.92%)
GILD   74.40 (+1.56%)
DIS   122.18 (+2.89%)
NFLX   421.97 (-1.25%)
BAC   25.99 (+4.63%)
BA   173.16 (+12.95%)
Log in

Compare Stocks

Enter up to five stock symbols separated by a comma or space (ex. BAC,WFC,JPM,LON:BARC).
Date Range: 

 Inspire Medical SystemsAtrionCardiovascular SystemsLuminexAtriCure
SymbolNYSE:INSPNASDAQ:ATRINASDAQ:CSIINASDAQ:LMNXNASDAQ:ATRC
Price Information
Current Price$86.55$653.15$38.02$31.14$44.94
52 Week RangeBuyN/ABuyHoldBuy
Beat the Market™ Rank
Overall Score1.21.31.51.51.4
Analysis Score2.40.03.31.02.4
Community Score2.22.32.62.02.9
Dividend Score0.03.30.01.70.0
Ownership Score1.01.01.01.01.0
Earnings & Valuation Score0.60.00.61.90.6
Analyst Ratings
Consensus RecommendationBuyN/ABuyHoldBuy
Consensus Price Target$80.20N/A$49.60$26.50$46.22
% Upside from Price Target-7.34% downsideN/A30.46% upside-14.90% downside2.85% upside
Trade Information
Market Cap$2.22 billion$1.19 billion$1.36 billion$1.45 billion$1.88 billion
Beta1.330.161.50.660.8
Average Volume416,1187,327311,831571,629481,441
Sales & Book Value
Annual Revenue$82.05 million$155.07 million$248.02 million$334.64 million$230.81 million
Price / Sales28.147.745.414.267.80
CashflowN/A$25.90 per share$0.09 per share$0.42 per shareN/A
Price / CashN/A25.22427.5574.06N/A
Book Value$5.81 per share$128.24 per share$4.25 per share$10.32 per share$6.25 per share
Price / Book14.905.098.953.027.19
Profitability
Net Income$-33,240,000.00$36.76 million$-250,000.00$-3,840,000.00$-35,190,000.00
EPS($1.40)N/A($0.01)($0.21)($1.07)
Trailing P/E RatioN/A33.58N/AN/AN/A
Forward P/E RatioN/AN/A81.95N/A
P/E GrowthN/AN/AN/AN/AN/A
Net Margins-47.30%23.06%-4.04%-1.81%-19.98%
Return on Equity (ROE)-29.14%15.57%-7.36%-1.25%-19.19%
Return on Assets (ROA)-23.04%14.09%-4.82%-1.08%-9.40%
Dividend
Annual PayoutN/A$6.20N/A$0.36N/A
Dividend YieldN/A0.95%N/A1.16%N/A
Three-Year Dividend GrowthN/AN/AN/AN/AN/A
Payout RatioN/AN/AN/AN/A N/A
Years of Consecutive Dividend GrowthN/A17 YearsN/A2 YearsN/A
Debt
Debt-to-Equity Ratio0.19%N/A0.15%0.04%0.32%
Current Ratio11.33%9.88%3.29%4.00%3.25%
Quick Ratio10.80%6.70%2.80%2.40%2.43%
Ownership Information
Institutional Ownership Percentage86.89%65.79%92.81%80.71%89.93%
Insider Ownership Percentage6.60%22.44%3.00%9.40%5.80%
Miscellaneous
EmployeesN/A5706521,247620
Shares Outstanding26.68 million1.84 million35.27 million45.79 million40.07 million
Next Earnings Date8/4/2020 (Estimated)8/5/2020 (Estimated)8/4/2020 (Estimated)7/29/2020 (Estimated)8/4/2020 (Estimated)
OptionableOptionableNot OptionableOptionableOptionableOptionable

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.